(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
-0.29% NOK 34.00
@ NOK34.00
Ausgestellt: 26 Apr 2024 @ 09:04
Rendite: 0.00%
Vorheriges Signal: Apr 25 - 16:13
Vorheriges Signal:
Rendite: -0.29 %
Live Chart Being Loaded With Signals
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics...
Stats | |
---|---|
Tagesvolumen | 4 319.00 |
Durchschnittsvolumen | 80 958.00 |
Marktkapitalisierung | 592.72M |
EPS | NOK0.390 ( 2023-11-01 ) |
Nächstes Ertragsdatum | ( NOK0 ) 2024-05-31 |
Last Dividend | NOK0.998 ( 2010-04-13 ) |
Next Dividend | NOK0 ( N/A ) |
P/E | 28.81 |
ATR14 | NOK0.800 (2.35%) |
Volumen Korrelation
Navamedic ASA Korrelation
10 Am meisten positiv korreliert | |
---|---|
NORSE.OL | 0.895 |
SMOP.OL | 0.871 |
NTEL.OL | 0.871 |
TOM.OL | 0.868 |
ENDUR.OL | 0.839 |
XXL.OL | 0.838 |
KIT.OL | 0.832 |
SNI.OL | 0.826 |
BORR.OL | 0.815 |
AYFIE.OL | 0.813 |
10 Am meisten negativ korreliert | |
---|---|
AKBM.OL | -0.895 |
ODL.OL | -0.895 |
SCATC.OL | -0.893 |
SBX.OL | -0.87 |
OKEA.OL | -0.858 |
VOLUE.OL | -0.857 |
PHO.OL | -0.854 |
FRO.OL | -0.852 |
TRVX.OL | -0.846 |
XPLRA.OL | -0.842 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Navamedic ASA Korrelation - Währung/Rohstoff
Navamedic ASA Finanzdaten
Annual | 2023 |
Umsatz: | NOK512.00M |
Bruttogewinn: | NOK199.05M (38.88 %) |
EPS: | NOK0 |
FY | 2023 |
Umsatz: | NOK512.00M |
Bruttogewinn: | NOK199.05M (38.88 %) |
EPS: | NOK0 |
FY | 2022 |
Umsatz: | NOK382.14M |
Bruttogewinn: | NOK163.52M (42.79 %) |
EPS: | NOK1.750 |
FY | 2021 |
Umsatz: | NOK278.44M |
Bruttogewinn: | NOK111.74M (40.13 %) |
EPS: | NOK0.00774 |
Financial Reports:
No articles found.
Navamedic ASA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
NOK0 (N/A) |
First Dividend | NOK0.998 | 2010-04-13 |
Last Dividend | NOK0.998 | 2010-04-13 |
Next Dividend | NOK0 | N/A |
Payout Date | 2010-04-27 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | NOK0.998 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.02 | -- |
Div. Sustainability Score | 5.91 | |
Div.Growth Potential Score | 0.831 | |
Div. Directional Score | 3.37 | -- |
Year | Amount | Yield |
---|---|---|
2010 | NOK0.998 | 17.80% |
2011 | NOK0 | 0.00% |
2012 | NOK0 | 0.00% |
2013 | NOK0 | 0.00% |
2014 | NOK0 | 0.00% |
2015 | NOK0 | 0.00% |
2016 | NOK0 | 0.00% |
2017 | NOK0 | 0.00% |
2018 | NOK0 | 0.00% |
2019 | NOK0 | 0.00% |
2020 | NOK0 | 0.00% |
2021 | NOK0 | 0.00% |
2022 | NOK0 | 0.00% |
2023 | NOK0 | 0.00% |
2024 | NOK0 | 0.00% |
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
ALNG.OL | Dividend King | 2023-11-27 | Quarterly | 2 | 6.60% | 7.04 |
OKEA.OL | Dividend Knight | 2023-12-01 | Quarterly | 3 | 5.65% | 6.86 |
SALM.OL | Dividend Knight | 2023-06-09 | Annually | 17 | 2.80% | 4.97 |
BWLPG.OL | Dividend Knight | 2023-11-17 | Quarterly | 11 | 1.68% | 4.46 |
ELK.OL | Dividend Knight | 2023-05-02 | Annually | 6 | 6.64% | 4.31 |
BWO.OL | Dividend Knight | 2023-11-20 | Quarterly | 14 | 0.87% | 3.96 |
ATEA.OL | Dividend Knight | 2023-11-20 | Annually | 16 | 2.97% | 3.45 |
HAFNI.OL | Dividend Knight | 2023-11-23 | Semi-Annually | 5 | 1.18% | 3.31 |
AKER.OL | Dividend Knight | 2023-11-07 | Semi-Annually | 20 | 2.99% | 3.13 |
AUSS.OL | Dividend Knight | 2023-05-26 | Annually | 17 | 3.23% | 2.93 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00752 | 1.500 | 9.85 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00735 | 1.200 | 9.76 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0175 | 1.500 | -0.916 | -1.374 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.111 | 0.800 | 9.44 | 7.56 | [1 - 3] |
quickRatioTTM | 0.469 | 0.800 | -1.948 | -1.558 | [0.8 - 2.5] |
cashRatioTTM | 0.201 | 1.500 | 9.99 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.287 | -1.500 | 5.22 | -7.83 | [0 - 0.6] |
interestCoverageTTM | 2.30 | 1.000 | -0.260 | -0.260 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.0520 | 2.00 | -0.0173 | -0.0346 | [0 - 30] |
freeCashFlowPerShareTTM | -0.180 | 2.00 | -0.0898 | -0.180 | [0 - 20] |
debtEquityRatioTTM | 0.675 | -1.500 | 7.30 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.378 | 1.000 | 7.03 | 7.03 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0404 | 1.000 | -1.192 | -1.192 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | -0.00595 | 1.000 | -1.144 | -1.144 | [0.2 - 2] |
assetTurnoverTTM | 0.977 | 0.800 | 6.82 | 5.46 | [0.5 - 2] |
Total Score | 5.91 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 152.06 | 1.000 | 10.00 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0175 | 2.50 | -0.589 | -1.374 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.180 | 2.00 | -0.0598 | -0.180 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.0520 | 2.00 | -0.0173 | -0.0346 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 1.751 | 1.500 | 1.657 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | -0.00175 | 1.000 | -2.54 | 0 | [0.1 - 0.5] |
Total Score | 0.831 |
Navamedic ASA
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.